Skip to main content
Erschienen in: Reactions Weekly 1/2020

01.06.2020 | Case report

Antivirals

Development of drug resistance: 3 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Fußnoten
1
All the three patients were identified from table 3 of the article.
 
Literatur
Zurück zum Zitat Bagaglio S, et al. A prospective italian study on baseline NS3 and NS5A resistance to direct-acting antivirals in a real-world setting of HIV-1/HCV coinfected patients and association with treatment outcome. Viruses 12: No. 3, 28 Feb 2020. Available from: URL: http://doi.org/10.3390/v12030269 Bagaglio S, et al. A prospective italian study on baseline NS3 and NS5A resistance to direct-acting antivirals in a real-world setting of HIV-1/HCV coinfected patients and association with treatment outcome. Viruses 12: No. 3, 28 Feb 2020. Available from: URL: http://​doi.​org/​10.​3390/​v12030269
Metadaten
Titel
Antivirals
Development of drug resistance: 3 case reports
Publikationsdatum
01.06.2020
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2020
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-020-79830-5

Weitere Artikel der Ausgabe 1/2020

Reactions Weekly 1/2020 Zur Ausgabe

Case report

Teriflunomide

Case report

Rituximab

Case report

Multiple drugs

Case report

Nivolumab